Invesco Ltd.
NYSE:IVZAsset Management
-$0.41 today
- Market cap
- $12.59B
- Beta
- 1.59
- P/E (TTM)
- -53.4
- EPS (TTM)
- -$0.54
- Dividend yield
- 2.94%
Volume 5.54M
Average 5.41M
IVZ Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Invesco Ltd.NYSE: IVZ
Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026
Stock-based compensation growth accelerates
Q2 FY2026 stock-based compensation of $34M (cash outflow) rose 123.7% year over year, ahead of the -36.9% change in trailing-twelve-month stock-based compensation. Over 3 fiscal years it compounded at -9.0% a year.
Context
- Stock-based compensation amounted to 1.3% of revenue in FY2025, down 0.5 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +123.7% holds above the trailing-twelve-month pace of -36.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 80M USD
- Year-over-year change
- -23.5%
- 4-year CAGR
- -13.1%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 80M | -23.5% |
| FY2024 | 2024-12-31 | 104.6M | -8.7% |
| FY2023 | 2023-12-31 | 114.6M | +7.9% |
| FY2022 | 2022-12-31 | 106.2M | -24.2% |
| FY2021 | 2021-12-31 | 140.1M | — |
Stock-Based Compensation vs competitors
How IVZ compares with its peers on the latest reported figures
- IVZ's LTM Jun 2026 stock-based compensation of $41.1M is the 5th largest of the 11 companies compared; the peer median is $14.25M.
- Its year-over-year change of -36.9% is the 6th highest of 10, against a peer median of -8.2%.
- Stock-based compensation amounts to 0.6% of revenue for IVZ, versus a peer median of 1.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $200M | +1.0% | +6.6% | 1.0% | |
| LTM Sep 2026 | $197.2M | -8.2% | +2.6% | — | |
| LTM Jun 2026 | $172.5M | -4.9% | -8.7% | 2.3% | |
| LTM Sep 2026 | $105.4M | -38.6% | +21.2% | 4.1% | |
| LTM Jun 2026 | $41.1M | -36.9% | -9.0% | 0.6% | |
| LTM Sep 2026 | $14.35M | -52.1% | -11.7% | 1.1% | |
| LTM Sep 2026 | $14.14M | -77.7% | +10.8% | 0.6% | |
| LTM Jun 2026 | $10.4M | -119.2% | +6.4% | 0.1% | |
| LTM Mar 2026 | $5.08M | -5.0% | -5.0% | 5.1% | |
| LTM Mar 2026 | $1.21M | +12.8% | -3.0% | 3.7% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding IVZ) | $14.25M | -8.2% | +2.6% | 1.1% | |
Competitors are the stored peer set for IVZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.97B | 925.5M | (96.9M) | 752.4M | (174.8M) |
| Depreciation & Amortization | 205.3M | 195.3M | 182.8M | 179.6M | 155.9M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 140.1M | 106.2M | 114.6M | 104.6M | 80M |
| Change in Working Capital | (294.3M) | (371.5M) | (173M) | 146.2M | (216.4M) |
| Accounts Receivables | 5.58B | 912.8M | 448.7M | 319.7M | (5.6M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (5.88B) | (1.28B) | (621.7M) | (173.5M) | (210.8M) |
| Other Non-Cash Items | (942.4M) | (152.3M) | 1.27B | 7.2M | 1.68B |
| Operating Cash Flow | 1.08B | 703.2M | 1.3B | 1.19B | 1.53B |
| Capital Expenditures | (108.8M) | (192.9M) | (164.3M) | (69.1M) | (84.3M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 236.5M |
| Purchases of Investments | (6.19B) | (2.95B) | (3.26B) | (4.47B) | (5.36B) |
| Sales of Investments | 5.41B | 2.74B | 3.21B | 4.48B | 4.23B |
| Other Investing Activities | 44.9M | 32.6M | (26.8M) | 126.8M | (300K) |
| Investing Cash Flow | (847.9M) | (375.6M) | (244.3M) | 68.4M | (974.4M) |
| Debt Repayment | 914.6M | (575M) | 251.2M | (922.9M) | 2.28B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (60.9M) | (244.7M) | (187.5M) | (79.3M) | (1.86B) |
| Dividends Paid | (544.5M) | (571.6M) | (594.7M) | (608.3M) | (581.9M) |
| Other Financing Activities | (191.9M) | 424.4M | (54.4M) | (51.1M) | 20.6M |
| Financing Cash Flow | 117.3M | (966.9M) | (585.4M) | (1.66B) | (149.5M) |
| Effect of Forex Changes | (39.7M) | (73.7M) | 26.4M | (32.4M) | 82.4M |
| Net Change in Cash | 307.8M | (713M) | 497.5M | (435.6M) | 483.8M |
| Free Cash Flow | 969.3M | 510.3M | 1.14B | 1.12B | 1.44B |
Invesco Ltd.
NYSE:IVZ
Intrinsic Alpha fair value
Locked
Current Price
$28.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.